Clinical validity of presynaptic dopaminergic imaging with 123 I-ioflupane and noradrenergic imaging with 123 I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework

Published 2017 View Full Article

Title

Clinical validity of presynaptic dopaminergic imaging with 123 I-ioflupane and noradrenergic imaging with 123 I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework

Authors

Keywords

I-ioflupane, Dopaminergic imaging, I-MIBG, Noradrenergic imaging, Alzheimer's disease, Dementia with Lewy bodies, Differential diagnosis, Biomarker-based diagnosis

Journal

NEUROBIOLOGY OF AGING

Volume 52, Issue -, Pages 228-242

Publisher

Elsevier BV

Online

2017-03-17

DOI

10.1016/j.neurobiolaging.2016.04.026

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

© Peeref 2019-2024. All rights reserved.